Beurs gesloten -
Nasdaq
22:30:01 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,27
USD
|
+9,49%
|
|
+4,40%
|
+23,76%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
6,25
|
13,05
|
12,77
|
3,575
|
4,176
|
5,242
|
-
|
-
|
Bedrijfswaarde
1 |
6,25
|
13,05
|
12,77
|
3,575
|
4,176
|
5,242
|
5,242
|
5,242
|
K/w-verhouding
|
-0,23
x
|
-1,2
x
|
-2,35
x
|
-0,62
x
|
-1,27
x
|
-1,24
x
|
-5,21
x
|
-5,55
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
445
x
|
41,5
x
|
14,6
x
|
2,56
x
|
2,08
x
|
2,46
x
|
3,69
x
|
2,89
x
|
Bedrijfswaarde/omzet
|
445
x
|
41,5
x
|
14,6
x
|
2,56
x
|
2,08
x
|
2,46
x
|
3,69
x
|
2,89
x
|
Bedrijfswaarde/EBITDA
|
-
|
-1,3
x
|
-2,94
x
|
-0,65
x
|
-1,17
x
|
-1,05
x
|
-0,57
x
|
-0,36
x
|
Bedrijfswaarde/FCF
|
-594.015
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
576
|
875
|
1.339
|
1.517
|
1.541
|
1.541
|
-
|
-
|
Referentieprijs
2 |
14,40
|
20,40
|
12,90
|
2,851
|
3,450
|
4,270
|
4,270
|
4,270
|
Datum van publicatie
|
26-03-20
|
16-03-21
|
22-03-22
|
22-03-23
|
21-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
0,0141
|
0,3146
|
0,876
|
1,396
|
2,005
|
2,131
|
1,421
|
1,815
|
EBITDA
1 |
-
|
-10,04
|
-4,337
|
-5,492
|
-3,564
|
-4,973
|
-9,156
|
-14,44
|
Bedrijfsresultaat (EBIT)
1 |
-10,62
|
-10,04
|
-4,337
|
-5,492
|
-3,564
|
-4,973
|
-9,156
|
-14,44
|
Operationele Marge
|
-75.512,59%
|
-3.189,84%
|
-495,12%
|
-393,57%
|
-177,78%
|
-233,36%
|
-644,33%
|
-795,87%
|
Resultaat voor belastingen (EBT)
1 |
-10,52
|
-9,946
|
-4,26
|
-5,357
|
-3,264
|
-4,736
|
-8,919
|
-14,21
|
Nettowinst (verlies)
1 |
-14,88
|
-7,844
|
-4,26
|
-5,357
|
-3,264
|
-4,736
|
-8,919
|
-14,21
|
Nettomarge
|
-105.822,19%
|
-2.493,13%
|
-486,36%
|
-383,87%
|
-162,78%
|
-222,24%
|
-627,66%
|
-782,81%
|
WPA
2 |
-63,30
|
-17,00
|
-5,500
|
-4,600
|
-2,710
|
-3,430
|
-0,8200
|
-0,7700
|
Free Cash Flow
|
-10,52
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-74.832,86%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
26-03-20
|
16-03-21
|
22-03-22
|
22-03-23
|
21-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
0,2604
|
0,251
|
0,3181
|
0,3412
|
0,363
|
0,3981
|
0,4842
|
0,5114
|
0,4976
|
0,5304
|
0,513
|
0,529
|
0,553
|
0,568
|
EBITDA
1 |
-1,026
|
-1,414
|
-1,324
|
-2,2
|
-0,7429
|
-1,278
|
-0,7314
|
-0,9412
|
-0,9336
|
-0,9911
|
-1,105
|
-1,184
|
-1,263
|
-1,421
|
Bedrijfsresultaat (EBIT)
1 |
-1,026
|
-1,414
|
-1,324
|
-2,2
|
-0,7429
|
-1,278
|
-0,7314
|
-0,9412
|
-0,9336
|
-0,9911
|
-1,105
|
-1,184
|
-1,263
|
-1,421
|
Operationele Marge
|
-393,96%
|
-563,44%
|
-416,38%
|
-644,82%
|
-204,66%
|
-321,03%
|
-151,06%
|
-184,05%
|
-187,62%
|
-186,87%
|
-215,4%
|
-223,82%
|
-228,39%
|
-250,18%
|
Resultaat voor belastingen (EBT)
1 |
-1,007
|
-1,39
|
-1,303
|
-2,188
|
-0,7045
|
-1,212
|
-0,6845
|
-0,8256
|
-0,8594
|
-0,9247
|
-1,026
|
-1,105
|
-1,263
|
-1,421
|
Nettowinst (verlies)
1 |
-1,007
|
-1,39
|
-1,303
|
-2,188
|
-0,7045
|
-1,212
|
-0,6845
|
-0,8256
|
-0,8594
|
-0,9247
|
-1,026
|
-1,105
|
-1,263
|
-1,421
|
Nettomarge
|
-386,77%
|
-553,71%
|
-409,67%
|
-641,25%
|
-194,09%
|
-304,44%
|
-141,38%
|
-161,44%
|
-172,71%
|
-174,34%
|
-200%
|
-208,88%
|
-228,39%
|
-250,18%
|
WPA
2 |
-1,300
|
-1,400
|
-1,200
|
-1,900
|
-0,6000
|
-1,000
|
-0,6000
|
-0,6900
|
-0,6900
|
-0,7700
|
-0,7900
|
-0,8300
|
-0,1500
|
-0,1700
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12-11-21
|
22-03-22
|
12-05-22
|
11-08-22
|
09-11-22
|
22-03-23
|
11-05-23
|
10-08-23
|
09-11-23
|
21-03-24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-10,5
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
26-03-20
|
16-03-21
|
22-03-22
|
22-03-23
|
21-03-24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +23,76% | 6,58 mln. | | +8,96% | 105 mld. | | -1,43% | 104 mld. | | +4,40% | 22,94 mld. | | -12,15% | 22,34 mld. | | -4,36% | 19,25 mld. | | -39,98% | 17,08 mld. | | -10,04% | 16,96 mld. | | +38,61% | 12,63 mld. | | +313,59% | 8,49 mld. |
Biotherapeutische geneesmiddelen
|